Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mid-low Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06304987
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 50
Not applicableUnknownNCT03413904
What this trial is testing

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer.

Who this might be right for
Rectal Cancer
IRCCS San Raffaele 184
Not applicableNot Yet RecruitingNCT06956976
What this trial is testing

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 1,596
Post-approval studies (Phase 4)Looking for participantsNCT07209787
What this trial is testing

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Who this might be right for
Rectal Cancer
Beijing Chao Yang Hospital 966
Not applicableUnknownNCT03222557
What this trial is testing

Electroacupuncture for Postoperative Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer

Who this might be right for
Postoperative IleusRectal Cancer
Chinese University of Hong Kong 164
Not applicableNot Yet RecruitingNCT07821437
What this trial is testing

Preoperative Nasal Intestinal Obstruction Catheter Mediated Terminal Ileum Fecal Diversion Versus Intraoperative Protective Ileostomy for Preventing Anastomotic Leakage After Mid Low Rectal Cancer Surgery: A Non Inferiority, Prospective, Multicenter Randomized Controlled Trial

Who this might be right for
Rectal Cancer Patients
First Affiliated Hospital of Wenzhou Medical University 500
Not applicableStudy completedNCT06024356
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 47
Large-scale testing (Phase 3)Looking for participantsNCT07505472
What this trial is testing

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Who this might be right for
Rectal Cancer
The First Hospital of Jilin University 212
Not applicableUnknownNCT02165800
What this trial is testing

Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Who this might be right for
Rectum Neoplasms
Third Affiliated Hospital, Sun Yat-Sen University 667
Not applicableNot Yet RecruitingNCT04200027
What this trial is testing

Robotic vs. TaTME Rectal Surgery (ROTA STUDY)

Who this might be right for
Rectal Cancer
Odense University Hospital 330
Early research (Phase 1)UnknownNCT04906044
What this trial is testing

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more
The First Hospital of Jilin University 46
Large-scale testing (Phase 3)UnknownNCT01423214
What this trial is testing

A Trial to Assess Robot-assisted Surgery and Laparoscopy-assisted Surgery in Patients With Mid or Low Rectal Cancer

Who this might be right for
Rectal Cancer
Kyungpook National University Hospital 540
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662278
What this trial is testing

RSIFN-co in Combination With Total Neo-adjuvant Therapy in Subjects With Mid-low Locally Advanced Rectal Cancer

Who this might be right for
Mid-low Locally Advanced Rectal Cancer
Sichuan Huiyang Life Science and Technology Corporation 90
Large-scale testing (Phase 3)UnknownNCT02736942
What this trial is testing

COLOR III Trial: Transanal vs Laparoscopic TME

Who this might be right for
Rectal CarcinomaSurgery
Amsterdam UMC, location VUmc 1,104
Testing effectiveness (Phase 2)Looking for participantsNCT07162714
What this trial is testing

SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer

Who this might be right for
Rectal CancerRadiationAK112
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07068763
What this trial is testing

Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer

Who this might be right for
Rectal Cancer
Sir Run Run Shaw Hospital 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06014944
What this trial is testing

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

Who this might be right for
Rectal Cancer
Changhai Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT04095299
What this trial is testing

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

Who this might be right for
Cancer of Rectum
Vejle Hospital 162
Not applicableLooking for participantsNCT03573791
What this trial is testing

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

Who this might be right for
Rectal CancerCancer of RectumCancer of the Rectum+4 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 152
Not applicableUnknownNCT03042000
What this trial is testing

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 1,200
Next Page